Cargando…
Aptamer Therapeutics in Cancer: Current and Future
Aptamer-related technologies represent a revolutionary advancement in the capacity to rapidly develop new classes of targeting ligands. Structurally distinct RNA and DNA oligonucleotides, aptamers mimic small, protein-binding molecules and exhibit high binding affinity and selectivity. Although thei...
Autores principales: | Morita, Yoshihiro, Leslie, Macall, Kameyama, Hiroyasu, Volk, David E., Tanaka, Takemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876655/ https://www.ncbi.nlm.nih.gov/pubmed/29562664 http://dx.doi.org/10.3390/cancers10030080 |
Ejemplares similares
-
Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer
por: Morita, Yoshihiro, et al.
Publicado: (2020) -
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
por: Hills, Natalie, et al.
Publicado: (2021) -
Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas
por: Morita, Yoshihiro, et al.
Publicado: (2017) -
Aptamer Microarrays—Current Status and Future Prospects
por: Witt, Martin, et al.
Publicado: (2015) -
Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare
por: Pathak, Rashmi, et al.
Publicado: (2023)